Study aims to stop overdosing obese patients on critical immune drug
NCT ID NCT04818177
Summary
This study aimed to find the best way to dose an immune-boosting medication called immunoglobulin G (IVIG) for people with obesity. Researchers measured drug levels in the blood of 40 adults already receiving IVIG treatment to see how body weight affects the dose needed. The goal was to gather evidence to prevent side effects from giving too much medication while still ensuring it works effectively.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Robert Wood Johnson University Hospital Somerset
Somerville, New Jersey, 08876, United States
Conditions
Explore the condition pages connected to this study.